$12.74
+0.22 (+1.76%)
Open$12.73
Previous Close$12.52
Day High$13.22
Day Low$12.25
52W High$45.00
52W Low$8.46
Volume—
Avg Volume151.8K
Market Cap297.28M
P/E Ratio—
EPS$-12.98
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+119.4% upside
Current
$12.74
$12.74
Target
$27.95
$27.95
$18.45
$27.95 avg
$35.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 46.2K | 614.9K | 107.82M |
| Net Income | -353,564,993 | -4,231,495,926 | -16,079,673 |
| Profit Margin | -762,355.6% | -724,237.8% | -14.9% |
| EBITDA | -332,200,737 | -4,196,684,842 | -19,078,562 |
| Free Cash Flow | — | — | -8,704,547 |
| Rev Growth | -92.5% | -92.5% | +2.1% |
| Debt/Equity | — | — | 0.51 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |